Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hubei Huaqiang High-Tech Co (SHSE:688151) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Hubei Huaqiang High-Tech Co EBITDA Margin % Related Terms
Hubei Huaqiang High-Tech Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688151 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Hubei Huaqiang High-Tech Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hubei Huaqiang High-Tech Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hubei Huaqiang High-Tech Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Hubei Huaqiang High-Tech Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hubei Huaqiang High-Tech Co (SHSE:688151) has a EBITDA Margin % of -4.19% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hubei Huaqiang High-Tech Co and its competitors. Over the past decade, Hubei Huaqiang High-Tech Co's EBITDA Margin % has ranged from 8.29 to 36.18. According to the industry distribution chart, Hubei Huaqiang High-Tech Co ranks #394 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 48.2%.
Is Hubei Huaqiang High-Tech Co's EBITDA Margin % too high?
Hubei Huaqiang High-Tech Co's current EBITDA Margin % is -4.19%. Over the past 10 years, this metric has ranged from a low of 8.29 to a high of 36.18. Based on the distribution chart, Hubei Huaqiang High-Tech Co ranks #394 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Hubei Huaqiang High-Tech Co has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hubei Huaqiang High-Tech Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Hubei Huaqiang High-Tech Co ranks #394 out of 817 companies for EBITDA Margin %. This puts Hubei Huaqiang High-Tech Co in the upper half of its industry. The industry median EBITDA Margin % is 7.44. Historically, Hubei Huaqiang High-Tech Co's own EBITDA Margin % has ranged from 8.29 to 36.18 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.44, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hubei Huaqiang High-Tech Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hubei Huaqiang High-Tech Co's current EBITDA Margin % is -4.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hubei Huaqiang High-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Hubei Huaqiang High-Tech Co (SHSE:688151) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥20.79, compared to a current price of ¥15.14 — trading 27.2% below its estimated fair value. The current EBITDA Margin % is -4.19%. Hubei Huaqiang High-Tech Co's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Hubei Huaqiang High-Tech Co (SHSE:688151), the current EBITDA Margin % is -4.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hubei Huaqiang High-Tech Co (SHSE:688151) Overvalued in 2026?
Based on GuruFocus' analysis, Hubei Huaqiang High-Tech Co stock appears to be undervalued.
The current stock price of ¥15.14 is trading 27.2% below its estimated GF Value™ of ¥20.79.
GuruFocus considers Hubei Huaqiang High-Tech Co to be Modestly Undervalued.
Key valuation signals for SHSE:688151:
EBITDA Margin %: -4.19%
GF Value™: ¥20.79 vs. price of ¥15.14 (27.2% below fair value)
No single metric tells the full story. See the SHSE:688151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hubei Huaqiang High-Tech Co Ltd is engaged in the Research, development, production and sales of special protective equipment, pharmaceutical packaging and medical device products.
60GF Score
Get the complete analysis for SHSE:688151
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688151 has been successfully added to your 
